Originally published September 20, 2019
The American Academy of Pediatrics National Coordinating Center for Epilepsy and Epilepsy Foundation of America are hosting a 10-session learning collaborative:
Managing Students with Seizures ECHO: The...
Updated
Originally published September 16, 2019
What is ECHO Epilepsy/Neurology?
Cincinnati ECHO Epilepsy/Neurology teleconferences are free, interactive, webinar-based mentoring sessions to help you with the many critical aspects of accessing...
Approximately one-third of people with epilepsy suffer from refractory (or drug-resistant) epilepsy that is not controlled by anti-seizure drugs (ASDs). The recurrence of these uncontrolled seizures has a significant impact on their quality of life...
Research by Epilepsy Foundation grantee Dr. Gordon Buchanan and colleagues sought to study role of neurotransmitters, such as serotonin (5-HT) and norepinephrine (NE), in sudden unexpected death in epilepsy (SUDEP). Their work was published in an...
On November 21, 2019, the U.S. Food and Drug Administration approved cenobamate (XCOPRI®) for the treatment of focal epilepsy in adults. This medication will be available in the pharmacy by the spring or summer of 2020. XCOPRI was developed by SK...
